Longeveron
Business Services · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Life Science & Technology Park 1951 NW 7...Phone Number
(844) 470-2550Website
www.longeveron.comRevenue
<$5 MillionStock Symbol
LGVNIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
1
1
1
About Longeveron
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.Explore more
Longeveron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Longeveron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Longeveron is spiking on competitors!
Longeveron, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Longeveron has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Longeveron launches new products
Earning: See what the market has to say on Longeveron recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Longeveron had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Longeveron
Funding: Get notified immidiatlly once Longeveron has new funding data
Recommended Actions
Find VP level buyers at Longeveron
Find 3 more new buyers
Compare Similar Companies to Longeveron
Compare insights from companies similar to Longeveron, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Longeveron is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Longeveron is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Longeveron.
Longeveron financials insights
Gather financial insights about Longeveron, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Share Placement
$20M
2024
Private Equity
$6.4M
Unspecified
$4.4M
2026
Private Equity
$15.9M
Longeveron Tech Stack
A closer look at the technologies used by Longeveron
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Promotion
Executive Move
Executive Moves, Promotion
Person-Based
Clinical Operations
Person-Based
Person-Based
Medical Research, Clinical Operations
Longeveron News & Media
Longeveron® Appoints Marie Washburn as Chief Financial Officer
Marie Washburn appointed CFO at Longeveron.Longeveron Inc. (LGVN) Shareholder/Analyst Call Prepared Remarks Transcript
Longeveron Inc. (LGVN) Shareholder/Analyst Call July 1, 2026 11:00 AM EDTCompany ParticipantsJoshua Hare - Co-Founder, Chief Science Officer & Executive...New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
Longeveron stem cell therapy Phase 2a clinical data in Alzheimer's disease selected for poster presentation at 2026 AAIC.Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
Longeveron (LGVN) granted Small or Medium-sized Enterprise (SME) status by the European Medicines Agency (EMA).
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Longeveron
Sign Up For FreeTo access detailed company insights
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is cond... Read More
